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ABSTRACT The chromosomal location of the human di-
hydrofolate reductase (DHFR; EC 1.5.1.3) gene that is ampli-
fied in a methotrexate-resistant human cell line has been inves-
tigated by screening a large number of human-mouse cell hy-
brids containing overlapping subsets of human chromosomes.
A correlation of genomic blotting data with the chromosome
constitution of the individual cell hybrids has allowed the as-
signment of the human DHFR gene to chromosome 5. This
chromosome assignment has been confirmed by the observa-
tion of a concomitant loss of the human DHFR gene and of
sensitivity to diphtheria toxin, a marker associated with chro-
mosome 5, in two human-mouse cell hybrids selected for
resistance to the toxin. Six EcoRI fragments of human DNA
containing DHFR pseudogenes or other DHFR-related se-
quences have been assigned to chromosomes other than chro-
mosome 5.
Recently, several cell variants resistant to high concentra-
tions of the folate antagonist methotrexate (MTX) have been
isolated from two different human cell lines, HeLa BU25
and VA2-B (1). As described for other mammalian culture
systems (2), these cell lines overproduce dihydrofolate re-
ductase (DHFR; 5,6,7,8-tetrahydrofolate:NADP+ oxidore-
ductase, EC 1.5.1.3), the target enzyme of MTX (1), as a
consequence of selective amplification of the structural gene
for DHFR (3). A striking feature of these MTX-resistant hu-
man cell variants is the pleomorphism of chromosomal alter-
ations they exhibit. These include a highly variable number
of double-minute chromosomes (DMs) (1), a homogeneously
staining region (HSR) in one or more marker chromosomes,
and a duplicated set of chromosomes in most cells of some
variants (1). To understand the nature and origin of these
chromosomal anomalies, the normal chromosomal location
of the DHFR structural gene must be defined, since, in ro-
dent cells (2) and human cells (unpublished data), both DMs
and HSRs have been shown to be the sites of amplified
DHFR genes. The recent cloning and characterization of hu-
man DHFR cDNAs (4) and the identification of the ampli-
fied DHFR structural gene fragments in EcoRI digests of ge-
nomic DNA (3) make it possible to study the segregation of
the human DHFR gene in human-mouse hybrid cells con-
taining overlapping subsets of human chromosomes and, by
this approach, to identify the chromosome in normal human
cells that is the site of the DHFR gene. In this study, the
human DHFR gene is assigned to chromosome 5, and six
EcoRI fragments containing DHFR pseudogenes or other
DHFR-related sequences are shown to be located in human
chromosomes other than 5.
MATERIALS AND METHODS
Materials. The restriction enzyme EcoRI was obtained
from New England BioLabs or Bethesda Research Labora-
tories, Escherichia coli DNA polymerase I from New En-
gland Nuclear, agarose from Sigma, dextran sulfate from
Pharmacia, nitrocellulose paper from Schleicher & Schuell,
and [a-32P]dCTP from Amersham.
Cell Lines and Conditions of Growth. The human cell lines
VA2-B and HeLa S3 were grown as described (1). The
mouse cell line A9 was grown in Eagle's phosphate medium
supplemented with 5% calf serum and azaguanine at 3
Mg/ml. The parents of the hybrid cell lines of the AHA series
were mouse A9 and human GM144; those of the 41pT series
and of the FRY series, mouse A9 and human GM126; and
those of the BDA series, mouse A9 and human GM589. The
human cell lines GM144 and GM126 are two fibroblast lines
with balanced chromosome translocations not involving
chromosome 5, and the cell line GM589 is a fibroblast line
with a balanced translocation of almost the entire chromo-
some 5 onto the long arm of chromosome 14 (Human Genet-
ic Mutant Cell Repository, Camden, NJ, 1982). Nine inde-
pendent hybrid clones, five subclones isolated from them by
dilution plating, and two diphtheria toxin-resistant sublines
derived from two independent clones were analyzed. The
hybrids were grown as described (5).
DNA Extraction. High molecular weight DNA from VA2-
B, HeLa S3, and A9 cells was prepared by the method of
Gross-Bellard et al. (6). Cell hybrid DNAs were prepared as
reported (5), additionally digested with RNase and Pronase,
extracted with phenol, precipitated with ethanol, and sus-
pended in 10 mM Tris-HCl/1 mM EDTA, pH 8.0.
Preparation of Radioactive Probes. Nick-translation of the
insert fragment of pHD84 (4), of the "probe 1.7," a deriva-
tive of pAT153 containing a 1.14-kilobase (kb) chromosome
5-specific single-copy DNA fragment (provided by P. Pear-
son), was carried out as described (4), using DNase I at 25
pg/ml, 4 units of E. coli DNA polymerase I, and 75-125 gCi
(1 Ci = 37 GBq) of [a-32P]dCTP (2000-3000 Ci/mmol) per
100 ng ofDNA, with the other unlabeled dcNTPs at 20 AsM, to
give a specific activity of 4-8 x 108 cpm/,ug. The BamHI
fragments e andfof the c-fms human oncogene (7), which is
located on human chromosome 5 (7, 8), were nick-translated
by a similar procedure.
DNA Transfer and Hybridization Techniques. DNA sam-
ples (amounts specified in figure legends) were digested to
completion with an excess of EcoRI restriction enzyme,
electrophoresed through a 0.7% agarose slab gel, and trans-
ferred to nitrocellulose filters by the method of Southern (9).
Abbreviations: MTX, methotrexate; DHFR, dihydrofolate reduc-
tase; DM, double-minute chromosome; HSR, homogeneously stain-
ing region; kb, kilobase(s).
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Hybridization with the 32P-labeled probe was carried out as
described (3), except for the absence of poly(cytidylic acid),
using 1.5-2.0 x 107 cpm of probe per filter in 5 ml of hybrid-
ization buffer. The filters were washed at 680C once with 6x
NaClI/Cit (lx NaClI/Cit = 0.15 M NaCl/0.015 M sodium ci-
trate)/10x Denhardt's solution (10)/0.1% sodium pyrophos-
phate/0.1% NaDodSO4 for 30 min, three times with 2x
NaClICit/0. 1% NaDodSO4, and three times with 0.5 x NaCl/
Cit/0. 1% NaDodSO4, 20 min each. The filters were then
dried and exposed for autoradiography (4).
Isozyme and Karyotype Analysis. All clones and subclones
were subjected to isozyme analysis and most were karyo-
typed; furthermore, the DNA from the majority of the hy-
brids was also tested with chromosome 5-specific probes
(BamHI fragments e andfof the c-fms human oncogene and
"probe 1.7") and with a chromosome 12-specific probe (5).
The isozyme tests were previously described (5). The chro-
mosome constitution of the hybrids was determined on 25-
50 Giemsa-banded metaphases per hybrid. The following cri-
teria were used for characterization of the cell hybrid lines:
A cell line was scored positive (+) for a human chromosome
when its presence was revealed by appropriate isozyme
expression and by karyotypic identification in >20% of
metaphases; in some cases, a clear karyotypic identification
alone or isozyme expression in the absence of karyotype
data was used for positive chromosome scoring. When no
isozyme markers were expressed and when, in the karyo-
typed hybrids, <5% of cells exhibited the specific human
chromosome, the hybrid was scored negative (-). In the
case of chromosome 5, the results of the specific probe hy-
bridization assays were also used as criteria, and they were
always found to be in agreement with the other scoring crite-
ria, so that all scorings for chromosome 5 were based on at
least two criteria. A hybrid was scored as weakly positive
(+/-) when the chromosome was present in 5-20% of meta-
phases and the isozyme analysis gave inconsistent results in
multiple assays. In cases in which the isozyme and karyo-
type data were insufficient to clearly characterize a hybrid,
this was scored 0 and the corresponding data were not in-
cluded in the mapping summary. In the hybrids of the series
BDA deriving from A9 and the human fibroblast line GM589
that were positive for chromosome 5 by karyotypic analysis,
both translocated and nontranslocated chromosomes 5 were
observed and scored. In three of these hybrids (10a3-1, 10a3-
4, and 10a3-6), the translocated chromosomes 5 were pre-
dominant (83-100%), in two other hybrids (17b17 and
10a4aFa9_1), mostly nontranslocated chromosomes 5 were ob-
served (79% and 63%, respectively).
RESULTS
Organization of DHFR-Specific Sequences in Genomic
DNAs from Human and Mouse Cells. The plasmid pHD84 is a
human DHFR cDNA clone derived from the MTX-resistant
VA2-B derivative 6A3 and contains the complete human
DHFR-encoding sequence (3, 4). The coding sequence of hu-
man DHFR shows an 89% nucleotide sequence homology to
that of the mouse (11). The plasmid pHD84 was used to
screen human-mouse somatic cell hybrid DNAs for human
DHFR-specific sequences. Southern blots of EcoRI-digest-
ed human genomic DNA probed with pHD84 show a com-
plex pattern consisting of fragments of the human DHFR
gene that is amplified in VA2-B 6A3 cells and of fragments
containing other DHFR-specific sequences (3). Two of the
latter fragments have been shown to contain portions of an
intronless pseudogene (3), while the nature of the other
DHFR-related sequences is uncertain. In this paper, frag-
ments that hybridize to the DHFR pHD84 probe, but that do
not belong to the structural gene amplified in 6A3 cells, will
be referred to as DHFR-related sequences.
2 3
a
13-
_
6 -
4-
C- C-'1,
4
*-
W:-
w-
I.68
g
FIG. 1. Patterns of hybridization with a human DHFR probe of
EcoRI-digested DNA from human and mouse cell lines. DNA sam-
ples (10 jig) were digested to completion with EcoRI, electropho-
resed through agarose slab gels, transferred to nitrocellulose paper,
and hybridized with the 32P-labeled insert of pHD84. The numbers
on the left indicate the normal human DHFR gene fragments (also
marked by asterisks) and represent their sizes in kb, and the letters
refer to DNA fragments containing human DHFR-related se-
quences. The long arrows on the right of lane 4 indicate the mouse
DHFR gene fragments; the short arrows refer to DNA fragments
containing mouse DHFR-related sequences. The band correspond-
ing to the upper fragment containing mouse DHFR-related se-
quences appears with variable intensity in different blots and may
represent a fragment particularly resistant to EcoRI. Lane 1,
GM589; lane 2, HeLa S3; lane 3, VA2-B; lane 4, A9.
Fig. 1 illustrates the distribution of DHFR-specific se-
quences that hybridize to the pHD84 probe in EcoRI digests
of genomic DNA from the normal human fibroblast line
GM589 (lane 1), HeLa S3 (lane 2), and VA2-B, a human cell
line containing a moderate amplification of the human
DHFR gene (3) (lane 3). The fragments of the structural gene
amplified in VA2-B DNA, which correspond to those ampli-
fied in the DNA from the MTX-resistant VA2-B 6A3 cell line
(3), are 13, 6, 4, 1.8, and 1.6 kb in size. These fragments,
which span the entire reading frame for human DHFR, have
recently been shown to be a part of the human structural
gene for DHFR by molecular cloning and DNA sequence
analysis (12). The 1.6-, 4-, and 13-kb EcoRI fragments have
been cloned, and the organization of this portion of the gene
has been determined (13). Fragments not associated with the
structural gene are designated in Fig. 1 by letters a-g and
have molecular sizes of 18, 17, 3.8, 3.5, 2.3, 2, and -1.6 kb,
respectively (ref. 4 and present work). The two fragments d
and e contain the recently isolated intronless pseudogene (3)
mentioned above.
The hybridization pattern of an EcoRI digest of mouse A9
cell DNA probed with the human DHFR probe pHD84 is
shown in lane 4 of Fig. 1. The four expected EcoRI frag-
ments of the mouse DHFR gene can be seen (14), as indicat-
ed by long arrows. In addition, two previously unreported
mouse DNA fragments containing DHFR-related sequences
are detected by the human DHFR probe, as shown by short
arrows. The fragments of the human DHFR gene with sizes
of 13, 6, and 4 kb migrate to positions in the gel that corre-
spond closely to those of mouse DNA fragments hybridizing
with the DHFR probe. In contrast, the 1.8- and 1.6-kb gene
fragments are found in regions of the blot free of mouse-spe-
cific bands. Thus, it has been possible to score the human-
mouse hybrid DNAs for the human DHFR gene by using the
1.8- and 1.6-kb bands as diagnostic of the entire gene. How-
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FIG. 2. Patterns of hybridization with a human DHFR probe of
EcoRI digested DNA from human-mouse cell hybrid clones. DNA
samples [10 ,fig, except BDA 10a3-4 and BDA 10a3-6 (~2 pig)] di-
gested with EcoRI were treated as described for Fig. 1. (A) Lane 1,
GMS89, human parental line; lane 2, BDA 17b17; lane 3, BDA 10a3-
6. (B) Lane 4, HeLa S3; lane BDA l0a3-1; lane 6, BDA l0a3-4;
lane 7, BDA 10a4aFag-1; lane 8, BDA 14b25; lane 9, BDA 14b25-2;
lane 10, A9, mouse parental line. For an explanation of numbers,
letters, and arrows, see legend to Fig. 1. The asterisks indicate the
human DHFR gene fragments in the cell hybrid DNAs.
ever, bands corresponding to the other expected human
DHFR gene fragments were always observed whenever the
1.8- and 1.6-kb bands were present. Furthermore, in several
cases, from the intensity of the signal given by these other
bands (in particular the 13- and 6-kb bands) and/or the ab-
sence of expected mouse gene fragments, the association of
these bands with human gene fragments could be inferred.
One also sees in Fig. 1 that the human DNA fragments con-
talning DHFR-related sequences a, b, c, e, f, and g are not
obscured by cross-hybridizing mouse DNA fragments.
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FIG. 3. Patterns of hybridization with a human DHFR probe of
EcoRI-digested DNA from human-mouse hybrid cell DNAs. DNA
samples (10 ug) digested with EcoRI were treated as described for
Fig. 1. Lane 1, HeLa S3; lane 2, AHA 16e; lane 3, AHA 3d-2; lane 4,
FRY-1; lane 5, A9, mouse parental line. For an explanation of num-
bers, letters, and arrows, see legend to Fig. 1.
Analysis of the Human DHFR Gene and Related Sequences
in Human-Mouse Cell Hybrid DNAs. Southern blots of
EcoRI-digested DNA from several human-mouse cell hy-
brids probed with pHD84 are shown in Figs. 2 and 3. In al-
most all cell hybrid DNAs shown, the characteristic bands of
the mouse DHFR gene can be seen. By contrast, the frag-
ments of the human structural gene forDHFR (asterisks) are
present in only 5 of the 10 human-mouse DNA samples
shown. Two hybrids, BDA1Oa3-4 and BDA1Oa3-6, gave
weak hybridization signals, due to the lower amounts of
DNA available. However, the 1.8- and 1.6-kb bands were
clearly discernible (especially on the original autoradio-
gram); furthermore, the 13- and 6-kb bands, because of their
intensity, could be assigned with reasonable confidence to
human DHFR gene fragments. In all blots, one or more frag-
ments with human DHFR-related sequences are also ob-
served. The results of genomic blotting and chromosome
Table 1. Human chromosome distribution in human-mouse cell hybrids and summary of genomic blotting results
Reaction of genomic EcoRI Presence of human chromosome,
fragments with pHD84* as determined by human isozyme expression and by cytogenetic analysisW
Hybrid cell line DHFR a b c die f g 1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18 19 20 21 22 X
BDA14b25 - 0 - + 0/+ - + + - + + - - + 0 - - - - - + - - - - - - - - +
BDA14b25-2 - 0 - - 0/+ - + + + + - - - - - +- - + - - - - - +
BDA1Oa3-1 + + + + +/+ + 0 - + + - + +- + - + + + -- -+ + - - + - - +
BDA17b17 + + + + o/+ 0 0 + + + + -- + - - + - + + --+ + + + + +
FRY-1 - ---0/+ - + - - +
41pT2a* - + + + +/+ 0 + - + + + + +++ - + - + + + - ++ -+ + +
BDA1Oa3-4 + 0 + + +/+ 0 0 - + + 0 + + -0 - + - + 0 - - 0 0 - - + - O +
BDA1Oa3-6 + 0 0 0 0/+ 00 - + + 0 + + - - + - + 0 - - 0 O - - + - O +
AHA3d2 - --+ 0/+ 0 + - - ++ -0 0 - + + + - - - - + + - - 0 +
AHA16e - --+0/+ - + - - -+/---- + + + + + - - -+ + + + + +
AHA11a - ---0/- 0 0 - - -
- +
BDA10a4aFag- + 0 + + +/++ + ++ + +--+ + + -+. +
BDA1Oa3 + + + + 0/+ + + - + + + + + - + -+ + + - - --+ + + ---+
BDA1Oa3DT - + + + 0/+ + + - + 0 - - + - + 0 + + + + - -++ +- +- + +
BDA17b17-1 + 0 0 + 0/+ - ++/-+/-0 + + --+ 0 - + - + - - + + + +
BDA17b17-1DT - 0 0 + 0/+ - + +/ + ----O - - + - - - + + +
*+, Fragment(s) present; -, fragment(s) absent; 0, undetermined.
tSee Materials and Methods and ref. 5 for the techniques of isozyme and karyotype analysis.
tGenome blots not shown.
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FIG. 4. Correlation of resistance to diphtheria toxin with the loss
of the human DHFR gene (A) and the loss of DNA sequences com-
plementary to a human chromosome 5-specific probe (B) in two hu-
man-mouse cell hybrids. Two human-mouse cell hybrid clones
were grown in the presence of diphtheria toxin and a toxin-resistant
subline was derived from each (see text). (A) DNA samples (10 Psg)
digested with EcoRI were treated as described for Fig. 1. Lane 1,
HeLa S3; lane 2, BDA MOa3; lane 3, BDA 1Oa3DT, toxin-resistant;
lane 4, BDA 17b17-1; lane 5, BDA 17b17-1DT, toxin-resistant; lane
6, A9. Normal DHFR gene fragments in lanes 2 and 4 are indicated
by asterisks. (B) DNA samples (10 ytg) digested with EcoRI and
transferred to nitrocellulose paper were hybridized with 32P-labeled
probe 1.7 specific for human chromosome 5 (see text). Lane 7,
HeLa S3; lane 8, BDA 10a3; lane 9, BDA 1Oa3DT, toxin-resistant;
lane 10, BDA 17b17-1; lane 11, BDA 17b17-1DT, toxin-resistant;
lane 12, A9.
analysis for these and other cell hybrids described below are
detailed in Table 1. The data in Table 1 strongly suggest that
chromosome 5 contains the DHFR gene (see Discussion).
The results of Table 1 also indicate that none of the DNA
fragments containing human DHFR-related sequences seg-
regate with chromosome 5.
Correlation of Human DHFR Structural Gene, Chromo-
some 5 Markers, and Diphtheria Toxin Sensitivity in Human-
Mouse Cell Hybrids. The assignment of the human DHFR
gene to chromosome 5 indicated by the mapping experi-
ments discussed above suggested a confirmatory experiment
based upon the selectable loss of a marker previously
mapped in human chromosome 5. It has been shown that
sensitivity to diphtheria toxin in human-mouse cell hybrids
is associated with a gene or genes located in human chromo-
some 5 (15). Therefore, human-mouse cell hybrids can be
selected for the loss of human chromosome 5 by growing
them in the presence of diphtheria toxin. Two human-mouse
cell hybrids containing the human DHFR gene were exposed
to Connaught diphtheria toxin at 2 x 10' Lf units/ml (15),
and a toxin-resistant subline was isolated from each. The
four lines were subjected to isozyme and karyotype analysis
(Table 1); in particular, they were screened for expression of
hexosaminidase B, a human chromosome 5 marker (16), and
further tested for the presence of chromosome 5 by probing
genomic blots with a human chromosome 5 unique sequence
DNA marker (probe 1.7). By both criteria, the two cell lines
had retained human chromosome 5 while the two diphtheria
toxin-resistant derivatives had lost this chromosome. It
should be noticed that chromosome 5 was the only chromo-
some lost by both toxin-resistant sublines. The DNAs from
the four lines were then screened for the human DHFR
structural gene. Fig. 4 shows the results of the blotting ex-
periment utilizing the human DHFR probe (Fig. 4A, lanes 2-
4) or the chromosome 5-specific probe 1.7 (Fig. 4B, lanes 8-
11). The absence of the 1.8- and 1.6-kb human DHFR bands
from the DNA blots of the diphtheria toxin-resistant lines
indicates that the human DHFR gene has been lost. Thus,
the loss of chromosome 5 in the diphtheria toxin-resistant
lines is accompanied by the loss of the human DHFR gene.
This result strongly supports the assignment of the human
DHFR gene to chromosome 5.
Polymorphism of the probe 1.7 in human populations has
been reported (17). This is reflected in the appearance of ad-
ditional probe 1.7-related bands in HeLa cell DNA (Fig. 4B,
lane 7) and in the DNA from the cell hybrid BDA 17b17-1
(Fig. 4B, lane 10).
DISCUSSION
The distribution of the human DHFR gene in all the hybrid
cell lines analyzed, including the diphtheria toxin-resistant
derivatives, is summarized in Table 2. It is clear that chro-
mosome 5 is the only chromosome showing a complete con-
cordance of segregation with the DHFR gene. Other geno-
mic blotting data (not shown) have revealed the absence of
the DHFR gene in six additional human-mouse cell hybrids
lacking chromosome 5. We conclude that the DHFR struc-
tural gene that has been amplified in the human cell lines
VA2-B and VA2-B 6A3 resides in human chromosome 5.
The present analysis has also provided information con-
cerning the chromosomal location of several fragments con-
taining human DHFR-related sequences. Table 3 summa-
rizes the most probable chromosome assignment of each of
the EcoRI fragments b-g. Although the available data do not
Table 2. Assignment of the structural gene for DHFR to human chromosome 5
Segre- Number of hybrids showing concordant or discordant segregation of human DHFR gene with each chromosome
gation* 1 2 3 4 5t 6 7 8 9 10 11 12 13 14 15 16 17 18 19 20 21 22 X
Concordant
+/+ 1 5 6 4 7 5 0 3 1 5 3 6 2 2 1 2 3 2 2 5 2 2 7
-/- 6 7 2 4 8 7 7 4 5 5 5 5 5 6 8 6 7 5 6 7 6 4 1
Discordant
+/- 5 1 0 1 0 2 7 2 5 2 4 0 3 5 6 3 2 5 5 2 5 3 0
-/+ 2 2 4 5 0 2 1 3- 1 4 4 4 4 3 1 2 2 4 3 2 3 4 8
Total 7 3 4 6 0 4 8 5 6 6 8 4 7 8 7 5 4 9 8 4 8 7 8
Only the unambiguous data of Table 1 (+ or -) were used in the compilation of this table.
*In each case the first plus or minus refers to the presence or absence, respectively, of the human DHFR gene, as determined by genomic
blotting experiments. The second plus or minus refers to the presence or absence of the chromosome numbered on the top of the table, as
determined by isozyme and karyotype data.
tComplete concordance of segregation between the DHFR structural gene and human chromosome 5 indicates that the structural gene resides
on this chromosome.
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allow an unambiguous chromosome assignment for these
fragments, they do exclude most chromosomes, including
chromosome 5, as their sites. Two of these fragments, d and
e (Fig. 1), have recently been shown to contain an intronless
DHFR pseudogene, qiHDI (3). On the basis of the data re-
ported here, an assignment of the pseudogene u/HDJ to chro-
mosome 3 or X has been made, with the evidence strongly
favoring chromosome 3. Two other fragments, b and c (Fig.
1), because of their size and the intensity of the hybridization
signal, appear to be good candidates for containing two addi-
tional intronless DHFR pseudogenes that have recently been
isolated from human DNA libraries (13). In particular, frag-
ment b has a size (-17 kb) that is compatible with the >15-
kb EcoRI subfragment carrying the hDHFR-qi2 pseudogene
isolated from a fetal DNA library, and fragment c has a size
(-3.8 kb) very close to that of the fragment containing the
hDHFR-Vl pseudogene isolated from an adult DNA library.
The present analysis indicates that fragment b is located in
chromosome 2 or 6, while fragment c is located in chromo-
some 3 or X.
The nature of the other fragments producing faint bands in
the EcoRI restriction pattern of DHFR-specific sequences in
human genomic DNA (fragments a, f, and g, Fig. 1) is un-
known. The low intensity of the signals given by these frag-
ments with a DHFR cDNA probe and the chromosome
segregation pattern would exclude the possibility that they
represent DHFR genes with different EcoRI restriction pat-
terns.
The present chromosome assignment of the human DHFR
gene is relevant to the origin of the chromosomal anomalies,
DMs and HSRs, observed in several MTX-resistant cell lines
(1, 18, 19). The human MTX-resistant cell line VA2-B 6A3
exhibits an HSR containing amplified DHFR genes in the
long arm of a chromosome clearly distinct from chromosome
5 (unpublished data). HSRs observed in other human MTX-
resistant cell lines have been reported to be located in chro-
mosomes 6, 19 (ref. 18), and 10 (ref. 19). The observation in
human MTX-resistant cell lines of HSRs containing ampli-
fied DHFR genes in chromosomes other than chromosome 5
strongly suggests that a translocation event from chromo-
some 5 to other chromosomes has occurred in these cell
lines. A role for DMs in the amplification and translocation
of the DHFR gene has been suggested (2, 20), but very little
evidence has been reported about their possible involve-
ment. Recently, an apparent translocation and amplification
of the c-myc gene from its normal position in human chromo-
some 8 to HSRs in the X chromosome has been described in
malignant neuroendocrine cells derived from a human colon
carcinoma (21). In the present case, an interesting possibility
is suggested by the observation that the human genome con-
tains, besides the DHFR structural gene that is amplified in
6A3 cells, up to as many as six other loci showing homology
to the human DHFR probe. It is conceivable that transloca-
tion events involving homologous recombination between
the DHFR structural gene in chromosome 5 and other
Table 3. Mapping of DHFR structural gene, DHFR pseudogenes,
and other DHFR-related sequences in the human genome
EcoRI band* (ref.) Molecular size, kb Chromosome
DHFR fragment 13, 6, 4, 1.8, 1.6 5
b (hDHFR-qi2 ?) (13) 17 2 or 6
c (hDHFR-qJ ?) (13) 3.8 3 or X
die (OHDI) (4) 3.5/2.3 3 or X*
f 2 2or6
g
-1.6 3 or X
*See Fig. 1.
tSince band e is present in equal quantities in human male and fe-
male placental DNAs (data not shown), the most probable chromo-
some is no. 3.
DHFR-related sequences located elsewhere in the genome
are responsible for the formation of at least some of the
HSRs observed in MTX-resistant cell lines.
Finally, the chromosomal linkage between the DHFR
gene and the gene(s) conferring diphtheria toxin sensitivity
to human cells parallels the demonstrated presence of these
two loci in chromosome 2 of Chinese hamster cells (22-24).
It should also be mentioned that three other genes, leuS,
emtB, and chr, are linked to the DHFR gene in both human
chromosome 5 and Chinese hamster chromosome 2 (25).
Considering the distance between these loci, the above ob-
servations provide a striking example of conservation of
gene organization among mammalian species.
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